A Qualitative Study of Increasing β-Blocker Use After Myocardial Infarction
Open Access
- 23 May 2001
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 285 (20), 2604-2611
- https://doi.org/10.1001/jama.285.20.2604
Abstract
Randomized clinical trials have demonstrated the efficacy of β-blocker use in reducing mortality and future cardiac events after acute myocardial infarction (AMI).1 Based on substantial evidence, clinical practice guidelines for AMI published by the American College of Cardiology and the American Heart Association2 strongly recommend the use of β-blockers for secondary prevention after AMI.Keywords
This publication has 17 references indexed in Scilit:
- Trends in acute myocardial infarction management: use of the national registry of myocardial infarction in quality improvementThe American Journal of Cardiology, 2000
- Improving the Quality of Care for Medicare Patients with Acute Myocardial Infarction: Results from the Cooperative Cardiovascular ProjectSurvey of Anesthesiology, 1999
- Assessing the Impact of Continuous Quality Improvement on Clinical Practice: What It Will Take to Accelerate ProgressThe Milbank Quarterly, 1998
- Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarctionJournal of the American College of Cardiology, 1995
- Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular ProjectPublished by American Medical Association (AMA) ,1995
- Audit of secondary prophylaxis after myocardial infarctionBMJ, 1994
- Beta blocker use in the treatment of community hospital patients discharged after myocardial infarctionJournal of General Internal Medicine, 1994
- Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1‐year mortality rateClinical Cardiology, 1994
- Evidence for the effectiveness of CME. A review of 50 randomized controlled trialsJAMA, 1992
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985